Tag Archives: China

China is world leader in nanotechnology and in other fields too?

State of Chinese nanoscience/nanotechnology

China claims to be the world leader in the field in a white paper announced in an August 29, 2017 Springer Nature press release,

Springer Nature, the National Center for Nanoscience and Technology, China and the National Science Library of the Chinese Academy of Sciences (CAS) released in both Chinese and English a white paper entitled “Small Science in Big China: An overview of the state of Chinese nanoscience and technology” at NanoChina 2017, an international conference on nanoscience and technology held August 28 and 29 in Beijing. The white paper looks at the rapid growth of China’s nanoscience research into its current role as the world’s leader [emphasis mine], examines China’s strengths and challenges, and makes some suggestions for how its contribution to the field can continue to thrive.

The white paper points out that China has become a strong contributor to nanoscience research in the world, and is a powerhouse of nanotechnology R&D. Some of China’s basic research is leading the world. China’s applied nanoscience research and the industrialization of nanotechnologies have also begun to take shape. These achievements are largely due to China’s strong investment in nanoscience and technology. China’s nanoscience research is also moving from quantitative increase to quality improvement and innovation, with greater emphasis on the applications of nanotechnologies.

“China took an initial step into nanoscience research some twenty years ago, and has since grown its commitment at an unprecedented rate, as it has for scientific research as a whole. Such a growth is reflected both in research quantity and, importantly, in quality. Therefore, I regard nanoscience as a window through which to observe the development of Chinese science, and through which we could analyze how that rapid growth has happened. Further, the experience China has gained in developing nanoscience and related technologies is a valuable resource for the other countries and other fields of research to dig deep into and draw on,” said Arnout Jacobs, President, Greater China, Springer Nature.

The white paper explores at China’s research output relative to the rest of the world in terms of research paper output, research contribution contained in the Nano database, and finally patents, providing insight into China’s strengths and expertise in nano research. The white paper also presents the results of a survey of experts from the community discussing the outlook for and challenges to the future of China’s nanoscience research.

China nano research output: strong rise in quantity and quality

In 1997, around 13,000 nanoscience-related papers were published globally. By 2016, this number had risen to more than 154,000 nano-related research papers. This corresponds to a compound annual growth rate of 14% per annum, almost four times the growth in publications across all areas of research of 3.7%. Over the same period of time, the nano-related output from China grew from 820 papers in 1997 to over 52,000 papers in 2016, a compound annual growth rate of 24%.

China’s contribution to the global total has been growing steadily. In 1997, Chinese researchers co-authored just 6% of the nano-related papers contained in the Science Citation Index (SCI). By 2010, this grew to match the output of the United States. They now contribute over a third of the world’s total nanoscience output — almost twice that of the United States.

Additionally, China’s share of the most cited nanoscience papers has kept increasing year on year, with a compound annual growth rate of 22% — more than three times the global rate. It overtook the United States in 2014 and its contribution is now many times greater than that of any other country in the world, manifesting an impressive progression in both quantity and quality.

The rapid growth of nanoscience in China has been enabled by consistent and strong financial support from the Chinese government. As early as 1990, the State Science and Technology Committee, the predecessor of the Ministry of Science and Technology (MOST), launched the Climbing Up project on nanomaterial science. During the 1990s, the National Natural Science Foundation of China (NSFC) also funded nearly 1,000 small-scale projects in nanoscience. In the National Guideline on Medium- and Long-Term Program for Science and Technology Development (for 2006−2020) issued in early 2006 by the Chinese central government, nanoscience was identified as one of four areas of basic research and received the largest proportion of research budget out of the four areas. The brain boomerang, with more and more foreign-trained Chinese researchers returning from overseas, is another contributor to China’s rapid rise in nanoscience.

The white paper clarifies the role of Chinese institutions, including CAS, in driving China’s rise to become the world’s leader in nanoscience. Currently, CAS is the world’s largest producer of high impact nano research, contributing more than twice as many papers in the 1% most-cited nanoscience literature than its closest competitors. In addition to CAS, five other Chinese institutions are ranked among the global top 20 in terms of output of top cited 1% nanoscience papers — Tsinghua University, Fudan University, Zhejiang University, University of Science and Technology of China and Peking University.

Nano database reveals advantages and focus of China’s nano research

The Nano database (http://nano.nature.com) is a comprehensive platform that has been recently developed by Nature Research – part of Springer Nature – which contains nanoscience-related papers published in 167 peer-reviewed journals including Advanced Materials, Nano Letters, Nature, Science and more. Analysis of the Nano database of nanomaterial-containing articles published in top 30 journals during 2014–2016 shows that Chinese scientists explore a wide range of nanomaterials, the five most common of which are nanostructured materials, nanoparticles, nanosheets, nanodevices and nanoporous materials.

In terms of the research of applications, China has a clear leading edge in catalysis research, which is the most popular area of the country’s quality nanoscience papers. Chinese nano researchers also contributed significantly to nanomedicine and energy-related applications. China is relatively weaker in nanomaterials for electronics applications, compared to other research powerhouses, but robotics and lasers are emerging applications areas of nanoscience in China, and nanoscience papers addressing photonics and data storage applications also see strong growth in China. Over 80% of research from China listed in the database explicitly mentions applications of the nanostructures and nanomaterials described, notably higher than from most other leading nations such as the United States, Germany, the UK, Japan and France.

Nano also reveals the extent of China’s international collaborations in nano research. China has seen the percentage of its internationally collaborated papers increasing from 36% in 2014 to 44% in 2016. This level of international collaboration, similar to that of South Korea, is still much lower than that of the western countries, and the rate of growth is also not as fast as those in the United States, France and Germany.

The United States is China’s biggest international collaborator, contributing to 55% of China’s internationally collaborated papers on nanoscience that are included in the top 30 journals in the Nano database. Germany, Australia and Japan follow in a descending order as China’s collaborators on nano-related quality papers.

China’s patent output: topping the world, mostly applied domestically

Analysis of the Derwent Innovation Index (DII) database of Clarivate Analytics shows that China’s accumulative total number of patent applications for the past 20 years, amounting to 209,344 applications, or 45% of the global total, is more than twice as many as that of the United States, the second largest contributor to nano-related patents. China surpassed the United States and ranked the top in the world since 2008.

Five Chinese institutions, including the CAS, Zhejiang University, Tsinghua University, Hon Hai Precision Industry Co., Ltd. and Tianjin University can be found among the global top 10 institutional contributors to nano-related patent applications. CAS has been at the top of the global rankings since 2008, with a total of 11,218 patent applications for the past 20 years. Interestingly, outside of China, most of the other big institutional contributors among the top 10 are commercial enterprises, while in China, research or academic institutions are leading in patent applications.

However, the number of nano-related patents China applied overseas is still very low, accounting for only 2.61% of its total patent applications for the last 20 years cumulatively, whereas the proportion in the United States is nearly 50%. In some European countries, including the UK and France, more than 70% of patent applications are filed overseas.

China has high numbers of patent applications in several popular technical areas for nanotechnology use, and is strongest in patents for polymer compositions and macromolecular compounds. In comparison, nano-related patent applications in the United States, South Korea and Japan are mainly for electronics or semiconductor devices, with the United States leading the world in the cumulative number of patents for semiconductor devices.

Outlook, opportunities and challenges

The white paper highlights that the rapid rise of China’s research output and patent applications has painted a rosy picture for the development of Chinese nanoscience, and in both the traditionally strong subjects and newly emerging areas, Chinese nanoscience shows great potential.

Several interviewed experts in the survey identify catalysis and catalytic nanomaterials as the most promising nanoscience area for China. The use of nanotechnology in the energy and medical sectors was also considered very promising.

Some of the interviewed experts commented that the industrial impact of China’s nanotechnology is limited and there is still a gap between nanoscience research and the industrialization of nanotechnologies. Therefore, they recommended that the government invest more in applied research to drive the translation of nanoscience research and find ways to encourage enterprises to invest more in R&D.

As more and more young scientists enter the field, the competition for research funding is becoming more intense. However, this increasing competition for funding was not found to concern most interviewed young scientists, rather, they emphasized that the soft environment is more important. They recommended establishing channels that allow the suggestions or creative ideas of the young to be heard. Also, some interviewed young researchers commented that they felt that the current evaluation system was geared towards past achievements or favoured overseas experience, and recommended the development of an improved talent selection mechanism to ensure a sustainable growth of China’s nanoscience.

I have taken a look at the white paper and found it to be well written. It also provides a brief but thorough history of nanotechnology/nanoscience even adding a bit of historical information that was new to me. As for the rest of the white paper, it relies on bibliometrics (number of published papers and number of citations) and number of patents filed to lay the groundwork for claiming Chinese leadership in nanotechnology. As I’ve stated many times before, these are problematic measures but as far as I can determine they are almost the only ones we have. Frankly, as a Canadian, it doesn’t much matter to me since Canada no matter how you slice or dice it is always in a lower tier relative to science leadership in major fields. It’s the Americans who might feel inclined to debate leadership with regard to nanotechnology and other major fields and I leave it to to US commentators to take up the cudgels should they be inclined. The big bonuses here are the history, the glimpse into the Chinese perspective on the field of nanotechnology/nanoscience, and the analysis of weaknesses and strengths.

Coming up fast on Google and Amazon

A November 16, 2017 article by Christina Bonnington for Slate explores the possibility that a Chinese tech giant, Baidu,  will provide Google and Amazon serious competition in their quests to dominate world markets (Note: Links have been removed,

The company took a playful approach to the form—but it has functional reasons for the design, too. Baidu


One of the most interesting companies in tech right now isn’t based in Palo Alto, or San Francisco, or Seattle. Baidu, a Chinese company with headquarters in Beijing, is taking on America’s biggest and most innovative tech titans—with style.

Baidu, a titan in its own right, leapt onto the scene as a competitor to Google in the search engine space. Since then, the company, largely underappreciated here in the U.S., has focused on beefing up its artificial intelligence efforts. Former AI chief Andrew Ng, upon leaving the company in March, credited Baidu’s CEO Robin Li on being one of the first technology leaders to fully appreciate the value of deep learning. Baidu now has a 1,300 person AI group, and that investment in AI has helped the company catch up to older, more established companies like Google and Amazon—both in emerging spaces, such as autonomous vehicles, and in consumer tech, as its latest announcement shows.

On Thursday [November 16, 2017], Baidu debuted its entrants to the popular virtual assistant space: a connected speaker and two robots. Baidu aims for the speaker to compete against options such as Amazon’s Echo line, Google Home, and Apple HomePod. Inside, the $256 device will utilize Baidu’s DuerOS conversational artificial intelligence platform, which is already used in more than 100 different smart home brands’ products. DuerOS will let you use your voice to do things like ask the speaker for information, play music, or hail a cab. Called the Raven H, the speaker includes high-end audio components from Tymphany and a unique design jointly created by acquired startup Raven Tech and Swedish consumer electronics company Teenage Engineering.

While the focus is on exciting new technology products from Baidu, the subtext, such as it is, suggests US companies had best keep an eye on its Chinese competitor(s).

Dutch/Chinese partnership to produce nanoparticles at the touch of a button

Now back to China and nanotechnology leadership and the production of nanoparticles. This announcement was made in a November 17, 2017 news item on Azonano,

Delft University of Technology [Netherlands] spin-off VSPARTICLE enters the booming Chinese market with a radical technology that allows researchers to produce nanoparticles at the push of a button. VSPARTICLE’s nanoparticle generator uses atoms, the worlds’ smallest building blocks, to provide a controllable source of nanoparticles. The start-up from Delft signed a distribution agreement with Bio-Sun to make their VSP-G1 nanoparticle generator available in China.

A November 16, 2017 VSPARTICLE press release, which originated the news item,

“We are honoured to cooperate with VSPARTICLE and bring the innovative VSP-G1 nanoparticle generator into the Chinese market. The VSP-G1 will create new possibilities for researchers in catalysis, aerosol, healthcare and electronics,” says Yinghui Cai, CEO of Bio-Sun.

With an exponential growth in nanoparticle research in the last decade, China is one of the leading countries in the field of nanotechnology and its applications. Vincent Laban, CFO of VSPARTICLE, explains: “Due to its immense investments in IOT, sensors, semiconductor technology, renewable energy and healthcare applications, China will eventually become one of our biggest markets. The collaboration with Bio-Sun offers a valuable opportunity to enter the Chinese market at exactly the right time.”


Increasingly, scientists are focusing on nanoparticles as a key technology in enabling the transition to a sustainable future. Nanoparticles are used to make new types of sensors and smart electronics; provide new imaging and treatment possibilities in healthcare; and reduce harmful waste in chemical processes.


With the latest tools in nanotechnology, researchers are exploring the possibilities of building novel materials. This is, however, a trial-and-error method. Getting the right nanoparticles often is a slow struggle, as most production methods take a substantial amount of effort and time to develop.


With the VSP-G1 nanoparticle generator, VSPARTICLE makes the production of nanoparticles as easy as pushing a button. . Easy and fast iterations enable researchers to fast forward their research cycle, and verify their hypotheses.


Born out of the research labs of Delft University of Technology, with over 20 years of experience in the synthesis of aerosol, VSPARTICLE believes there is a whole new world of possibilities and materials at the nanoscale. The company was founded in 2014 and has an international sales network in Europe, Japan and China.


Bio-Sun was founded in Beijing in 2010 and is a leader in promoting nanotechnology and biotechnology instruments in China. It serves many renowned customers in life science, drug discovery and material science. Bio-Sun has four branch offices in Qingdao, Shanghai, Guangzhou and Wuhan City, and a nationwide sale network.

That’s all folks!

Café Scientifique Vancouver talk on January 30, 2018 and a couple of February 2018 art/sci events in Toronto


This could be a first for Café Scientifique Vancouver. From a January 28, 2018 Café Scientifique Vancouver announcement (received via email)

This is a reminder that our next café with biotech entrepreneur Dr.Andrew Tait (TUESDAY, JANUARY 30TH [2018] at 7:30PM) in the back room of YAGGER'S DOWNTOWN (433 W Pender).


The orange peel is something most of us may think of as a throw-away compost item, but it is so much more. Travel back in time 9,000 years to China, where orange peel was found in the first fermented alcoholic beverage, and return to today, where mandarin orange peel remains one of China’s top selling herbs that promotes digestion. Now meet Tait Laboratories Inc., a company that was founded based on one chemistry Ph.D. student’s idea, that mandarin orange peel has the potential to reverse incurable neurodegenerative diseases like multiple sclerosis. You will learn about the company’s journey through a scientific lens, from its early days to the present, having developed a mandarin orange peel product sold across Canada in over 1,000 stores including 400 Rexall pharmacies. You will leave with a basic understanding of how herbal products like the company’s mandarin orange peel-based product are developed and brought to market in Canada, and about the science that is required to substantiate health claims on this and other exciting new botanical products.


Dr. Andrew Tait is the founder of Tait Laboratories Inc., a company devoted to developing natural medicines from agricultural bi-products. After a B.Sc. in Biochemistry and M.Sc. in Chemistry from Concordia University (Montreal), he completed a Ph.D. in Chemistry at the
University of British Columbia [UBC].

Inspired by his thesis work on multiple sclerosis, he subsequently identified Traditional Chinese Medicines as having potential to treat a wide range of chronic diseases; he founded the company while finishing his graduate studies.

In 2012, he was invited to Ottawa to be awarded the NSERC [{Canada} Natural Sciences and Engineering Research Council] Innovation Challenge Award, for successfully translating his Ph.D. research to an entrepreneurial venture. In 2014, he was awarded the BC Food Processors Association “Rising Star” award.

Dr. Tait is a regularly invited speaker on the topics of entrepreneurship and the science supporting natural health products; he was keynote speaker in 2012 at the Annual Symposium of the Boucher Institute of Naturopathic Medicine (Vancouver) and in 2016 at the
Functional Foods and Natural Health Products Graduate Research Symposium (Winnipeg).

Supported by the Futurpreneur Canada, the Bank of Development of Canada, the UBC’s Entrepreneurship@UBC program, and the NSERC  and NRC  [{Canada} National Research Council] Industry Research Assistance Program (IRAP), he works with industrial and academic researchers developing safe, affordable, and clinically proven medicines. He successfully launched MS+ Mandarin Skin PlusÒ, a patent-pending digestive product now on shelf in over 1000 pharmacies and health food stores across Canada, including 400 Rexall pharmacies.

Dr. Tait mentors young companies as an Entrepreneur in Residence at both SFU [Simon Fraser University] Coast Capital Savings Venture Connection and also the Health Tech Innovation Hub and he also volunteers his time to mentor students of the Student Biotechnology Network.

Lest it be forgotten, many drugs and therapeutic agents are based on natural remedies; a fact often ignored in the discussion about drugs and natural remedies. In any event, I am surprised this talk is being hosted by Café Scientifique Vancouver which has tended to more ‘traditional’ (i.e., university academic) presentations without any hint of ‘alternative’ or ‘entrepreneurial’ aspects. I wonder if this is the harbinger of new things to come from the Café Scientifique Vancouver community.

Meanwhile, interested parties can find out more about Tait Laboratories on their company website. They are selling one product at this time (from the MS+ [Mandarin Skin Plus] product webpage,

MS+™ (Mandarin Skin Plus) is a revolutionary natural health product that aids with digestion and promotes gastrointestinal health. It is a patent-pending proprietary extract based on dry-aged mandarin orange peel, an ancient Traditional Chinese Medicine. This remedy has been safely used for centuries to relieve bloating, indigestion, diarrhea, nausea, upset stomach, cough with phlegm. Experience ULTIMATE DIGESTIVE RELIEF and top gastrointestinal health for only about a dollar a day!

Directions: take one capsule twice a day, up to six capsules per day. Swallow capsule directly OR dissolve powder in water.
60 vegan capsules for ~ 1 month supply

I would have liked to have seen a list of research papers and discussion of human clinical trials regarding their ‘digestive’ product. Will Tait be discussing his research and results into what seems to be a new direction (i.e., the use of mandarin skin peel-derived therapeutics for neurodegenerative diseases)?

I don’t think I’m going to make it to the talk but should anyone who attends care to answer the question, please feel free to add a comment.

ArtSci Salon in Toronto

2018 is proving to be an active year for the ArtSci Salon folks in Toronto. They’ve just finished hosting a January 24-25, 2018 workshop and January 26, 2018 panel discussion on the gene-editing tool CRISPR/CAS9 (see my January 10, 2018 posting for a description).

Now they’ve announced another workshop and panel discussion on successive nights in February, the topic being: cells. From a January 29, 2018 ArtSci Salon announcement (received via email), Note: The panel discussion is listed first, then the workshop, then the artists’ biographies,


From the complex forms of the cell to the colonies created by the microbiota; from the undetectable chemical reactions activated by enzymes and natural processes to the environmental information captured through data visualization, the five local and international artists presenting tonight have developed a range of very diverse practices all inspired by the invisible, the undetectable and the microscopic.

We invite you to an evening of artist talks and discussion on the creative process of exploring the microscopic and using living organisms in art, on its potentials and implication for science and its popular dissemination, as well as on its ethics.

Robyn Crouch
Mellissa Fisher

FRIDAY, FEB 9, 2018
6:00-8:00 PM
RM 230

[Go to this page for access to registration]


FEB. 10, 2018
1266 Queen St West

[Go to this page for access to registration]


Design My Microbiome

Artist Mellissa Fisher invites participants to mould parts of her body in agar to create their own microbial version of her, alongside producing their own microbial portrait with painting techniques.

Cooking with the Invasive

Artist Shavon Madden invites participants to discuss invasive species like garlic mustard and cook invasive species whilst exploring, do species which we define and brand as invasive simply have no benefits?

Intoduction to Biological Staining

Artist & Scientist Julia Krolik invites participants to learn about 3 different types of biological staining and have a chance to try staining procedures.


The symbolic imagery that comes through Robyn’s work invites one’s gaze inward to the cellular realms. There, one discovers playful depictions of chemical processes; the unseen lattice upon which our macro­cosmic world is constructed. Technological advancements create windows into this molecular realm, and human consciousness acts as the interface between the seen and the unseen worlds. In her functional ceramic work, the influence of Chinese and Japanese tea ceremony encourages contem­plation and appreciation of a quiet
moment. The viewer-participant can lose their train of thought while meandering through geometry and biota, con­nected by strands of double-helical DNA. A flash of recognition, a momentary mirror.

Mellissa Fisher is a British Bio Artist based in Kent. Her practice explores the invisible world on our skin by using living organisms and by creating sculptures made with agar to show the public what the surface of our skin really looks like. She is best known for her work with bacteria and works extensively with collaborators in microbiology and immunology. She has exhibited an installation _ “Microbial Me”_with Professor Mark Clements and Dr Richard Harvey at The Eden Project for their permanent exhibition _“The Invisible You: The Human
Microbiome”._The installation included a living portrait in bacteria of the artists face as well as a time-lapse film of the sculpture growing.

Julia Krolik is a creative director, entrepreneur, scientist and award-winning artist. Her diverse background enables a rare cross-disciplinary empathy, and she continuously advocates for both art and science through several initiatives. Julia is the founder of Art the Science, a non-profit organization dedicated to facilitating artist residencies in scientific research laboratories to foster Canadian science-art culture and expand scientific knowledge communication to benefit the public. Through her consulting agency Pixels and Plans, Julia works with private and public organizations, helping them with strategy, data visualization and knowledge mobilization, often utilizing creative technology and skills-transfer workshops.

Shavon Madden is a Brampton based artist, specializing in sculptural, performance and instillation based work exploring the social injustices inflicted on the environment and its creatures. Her work focuses on challenging social-environmental and political ethics, through the embodied experience and feelings of self. She graduated from the University of Toronto Specializing in Art and Art History, along with studies in Environmental Science and will be on her way to Edinburgh for her MFA. Shavon has had works shown at Shelly Peterson, the Burlington Art Gallery and the Art Gallery of Mississauga, among many others. Website: www.greenheartartistry.com [4]

Working with metal for over 30+ years, Tosca was introduced to glass as an artistic medium in 2004. Through developing bodies of work incorporating metal + glass Tosca has been awarded scholarships at The Corning Museum of Glass, Pilchuck Glass School and The Penland school of Crafts. Her work has been featured at SOFA New York, Culture Canada,
Metalsmith Magazine, The Toronto Design Exchange, and the Memphis Metal Museum. She has been awarded residencies at Gullkistan, Nes, and the Ayatana Research Program. A long-term guest artist instructor at the Ontario Science Centre, Tosca continues to explore materials, code, BioArt, SciArt and teach Metal + Glass courses out of her studio in Toronto.

It seems that these February events and the two events with Marta de Menezes are part of the FACTT (transdisciplinary and transnational festival of art and science) Toronto, from the FACTT Toronto webpage,

FACTT Toronto – Festival of Art & Science posted in: blog, events

The Arte Institute, in partnership with Cultivamos Cultura and ArtSi Salon, has the pleasure to announce FACTT – Festival of Art & Science in Toronto.

The Festival took place in Lisbon, New York, Mexico, Berlin and will continue in Toronto.
Exhibition: The Cabinet Project/ Art Sci Salon / FACTT


Andrew Carnie
Elaine Whittaker
Erich Berger
Joana Ricou
Ken Rinaldo
Laura Beloff and Maria Antonia Gonzalez Valerio
Marta de Menezes and Luís Graça
Pedro Cruz

Dates: Jan 26- feb 15 [2018 {sic}]

Where: Meet us on Jan 26 [2018] in the Lobby of the Physics Department, 255 Huron Street
University of Toronto
When: 4:45 PM

You may want to keep an eye on the ArtSci Salon website although I find their posting schedule a bit erratic. Sometimes, I get email notices for events that aren’t yet listed on their website.

Why don’t you CRISPR yourself?

It must have been quite the conference. Josiah Zayner plunged a needle into himself and claimed to have changed his DNA (deoxyribonucleic acid) while giving his talk. (*Segue: There is some Canadian content if you keep reading.*) From an Oct. 10, 2017 article by Adele Peters for Fast Company (Note: A link has been removed),

“What we’ve got here is some DNA, and this is a syringe,” Josiah Zayner tells a room full of synthetic biologists and other researchers. He fills the needle and plunges it into his skin. “This will modify my muscle genes and give me bigger muscles.”

Zayner, a biohacker–basically meaning he experiments with biology in a DIY lab rather than a traditional one–was giving a talk called “A Step-by-Step Guide to Genetically Modifying Yourself With CRISPR” at the SynBioBeta conference in San Francisco, where other presentations featured academics in suits and the young CEOs of typical biotech startups. Unlike the others, he started his workshop by handing out shots of scotch and a booklet explaining the basics of DIY [do-it-yourwelf] genome engineering.

If you want to genetically modify yourself, it turns out, it’s not necessarily complicated. As he offered samples in small baggies to the crowd, Zayner explained that it took him about five minutes to make the DNA that he brought to the presentation. The vial held Cas9, an enzyme that snips DNA at a particular location targeted by guide RNA, in the gene-editing system known as CRISPR. In this case, it was designed to knock out the myostatin gene, which produces a hormone that limits muscle growth and lets muscles atrophy. In a study in China, dogs with the edited gene had double the muscle mass of normal dogs. If anyone in the audience wanted to try it, they could take a vial home and inject it later. Even rubbing it on skin, Zayner said, would have some effect on cells, albeit limited.

Peters goes on to note that Zayner has a PhD in molecular biology and biophysics and worked for NASA (US National Aeronautics and Space Administration). Zayner’s Wikipedia entry fills in a few more details (Note: Links have been removed),

Zayner graduated from the University of Chicago with a Ph.D. in biophysics in 2013. He then spent two years as a researcher at NASA’s Ames Research Center,[2] where he worked on Martian colony habitat design. While at the agency, Zayner also analyzed speech patterns in online chat, Twitter, and books, and found that language on Twitter and online chat is closer to how people talk than to how they write.[3] Zayner found NASA’s scientific work less innovative than he expected, and upon leaving in January 2016, he launched a crowdfunding campaign to provide CRISPR kits to let the general public experiment with editing bacterial DNA. He also continued his grad school business, The ODIN, which sells kits to let the general public experiment at home. As of May 2016, The ODIN had four employees and operates out of Zayner’s garage.[2]

He refers to himself as a biohacker and believes in the importance in letting the general public participate in scientific experimentation, rather than leaving it segregated to labs.[2][4][1] Zayner found the biohacking community exclusive and hierarchical, particularly in the types of people who decide what is “safe”. He hopes that his projects can let even more people experiment in their homes. Other scientists responded that biohacking is inherently privileged, as it requires leisure time and money, and that deviance from the safety rules of concern would lead to even harsher regulations for all.[5] Zayner’s public CRISPR kit campaign coincided with wider scrutiny over genetic modification. Zayner maintained that these fears were based on misunderstandings of the product, as genetic experiments on yeast and bacteria cannot produce a viral epidemic.[6][7] In April 2015, Zayner ran a hoax on Craigslist to raise awareness about the future potential of forgery in forensics genetics testing.[8]

In February 2016, Zayner performed a full body microbiome transplant on himself, including a fecal transplant, to experiment with microbiome engineering and see if he could cure himself from gastrointestinal and other health issues. The microbiome from the donors feces successfully transplanted in Zayner’s gut according to DNA sequencing done on samples.[2] This experiment was documented by filmmakers Kate McLean and Mario Furloni and turned into the short documentary film Gut Hack.[9]

In December 2016, Zayner created a fluorescent beer by engineering yeast to contain the green fluorescent protein from jellyfish. Zayner’s company, The ODIN, released kits to allow people to create their own engineered fluorescent yeast and this was met with some controversy as the FDA declared the green fluorescent protein can be seen as a color additive.[10] Zayner, views the kit as a way that individual can use genetic engineering to create things in their everyday life.[11]

I found the video for Zayner’s now completed crowdfunding campaign,

I also found The ODIN website (mentioned in the Wikipedia essay) where they claim to be selling various gene editing and gene engineering kits including the CRISPR editing kits mentioned in Peters’ article,

In 2016, he [Zayner] sold $200,000 worth of products, including a kit for yeast that can be used to brew glowing bioluminescent beer, a kit to discover antibiotics at home, and a full home lab that’s roughly the cost of a MacBook Pro. In 2017, he expects to double sales. Many kits are simple, and most buyers probably aren’t using the supplies to attempt to engineer themselves (many kits go to classrooms). But Zayner also hopes that as people using the kits gain genetic literacy, they experiment in wilder ways.

Zayner sells a full home biohacking lab that’s roughly the cost of a MacBook Pro. [Photo: The ODIN]

He questions whether traditional research methods, like randomized controlled trials, are the only way to make discoveries, pointing out that in newer personalized medicine (such as immunotherapy for cancer, which is personalized for each patient), a sample size of one person makes sense. At his workshop, he argued that people should have the choice to self-experiment if they want to; we also change our DNA when we drink alcohol or smoke cigarettes or breathe in dirty city air. Other society-sanctioned activities are more dangerous. “We sacrifice maybe a million people a year to the car gods,” he said. “If you ask someone, ‘Would you get rid of cars?’–no.” …

US researchers both conventional and DIY types such as Zayner are not the only ones who are editing genes. The Chinese study mentioned in Peters’ article was written up in an Oct. 19, 2015 article by Antonio Regalado for the MIT [Massachusetts Institute of Technology] Technology Review (Note: Links have been removed),

Scientists in China say they are the first to use gene editing to produce customized dogs. They created a beagle with double the amount of muscle mass by deleting a gene called myostatin.

The dogs have “more muscles and are expected to have stronger running ability, which is good for hunting, police (military) applications,” Liangxue Lai, a researcher with the Key Laboratory of Regenerative Biology at the Guangzhou Institutes of Biomedicine and Health, said in an e-mail.

Lai and 28 colleagues reported their results last week in the Journal of Molecular Cell Biology, saying they intend to create dogs with other DNA mutations, including ones that mimic human diseases such as Parkinson’s and muscular dystrophy. “The goal of the research is to explore an approach to the generation of new disease dog models for biomedical research,” says Lai. “Dogs are very close to humans in terms of metabolic, physiological, and anatomical characteristics.”

Lai said his group had no plans breed to breed the extra-muscular beagles as pets. Other teams, however, could move quickly to commercialize gene-altered dogs, potentially editing their DNA to change their size, enhance their intelligence, or correct genetic illnesses. A different Chinese Institute, BGI, said in September it had begun selling miniature pigs, created via gene editing, for $1,600 each as novelty pets.

People have been influencing the genetics of dogs for millennia. By at least 36,000 years ago, early humans had already started to tame wolves and shape the companions we have today. Charles Darwin frequently cited dog breeding in The Origin of Species to demonstrate how evolution gradually occurs by a process of selection. With CRISPR, however, evolution is no longer gradual or subject to chance. It is immediate and under human control.

It is precisely that power that is stirring wide debate and concern over CRISPR. Yet at least some researchers think that gene-edited dogs could put a furry, friendly face on the technology. In an interview this month, George Church, a professor at Harvard University who leads a large effort to employ CRISPR editing, said he thinks it will be possible to augment dogs by using DNA edits to make them live longer or simply make them smarter.

Church said he also believed the alteration of dogs and other large animals could open a path to eventual gene editing of people. “Germline editing of pigs or dogs offers a line into it,” he said. “People might say, ‘Hey, it works.’ ”

In the meantime, Zayner’s ideas are certainly thought provoking. I’m not endorsing either his products or his ideas but it should be noted that early science pioneers such as Humphrey Davy and others experimented on themselves. For anyone unfamiliar with Davy, (from the Humphrey Davy Wikipedia entry; Note: Links have been removed),

Sir Humphry Davy, 1st Baronet PRS MRIA FGS (17 December 1778 – 29 May 1829) was a Cornish chemist and inventor,[1] who is best remembered today for isolating a series of substances for the first time: potassium and sodium in 1807 and calcium, strontium, barium, magnesium and boron the following year, as well as discovering the elemental nature of chlorine and iodine. He also studied the forces involved in these separations, inventing the new field of electrochemistry. Berzelius called Davy’s 1806 Bakerian Lecture On Some Chemical Agencies of Electricity[2] “one of the best memoirs which has ever enriched the theory of chemistry.”[3] He was a Baronet, President of the Royal Society (PRS), Member of the Royal Irish Academy (MRIA), and Fellow of the Geological Society (FGS). He also invented the Davy lamp and a very early form of incandescent light bulb.

Canadian content*

A Nov. 11, 2017 posting on the Canadian Broadcasting Corporation’s (CBC) Quirks and Quarks blog notes that self-experimentation has a long history and goes on to describe Zayner’s and others biohacking exploits before describing the legality of biohacking in Canada,

With biohackers entering into the space traditionally held by scientists and clinicians, it begs questions. Professor Timothy Caulfield, a Canada research chair in health, law and policy at the University of Alberta, says when he hears of somebody giving themselves biohacked gene therapy, he wonders: “Is this legal? Is this safe? And if it’s not safe, is there anything that we can do about regulating it? And to be honest with you that’s a tough question and I think it’s an open question.”

In Canada, Caulfield says, Health Canada focuses on products. “You have to have something that you are going to regulate or you have to have something that’s making health claims. So if there is a product that is saying I can cure X, Y, or Z, Health Canada can say, ‘Well let’s make sure the science really backs up that claim.’ The problem with these do-it-yourself approaches is there isn’t really a product. You know these people are experimenting on themselves with something that may or may not be designed for health purposes.”

According to Caufield, if you could buy a gene therapy kit that was being marketed to you to biohack yourself, that would be different. “Health Canada could jump in. But right here that’s not the case,” he says.

There are places in the world that do regulate biohacking, says Caulfield. “Germany, for example, they have specific laws for it. And here in Canada we do have a regulatory framework that says that you cannot do gene therapy that will alter the germ line. In other words, you can’t do gene therapy or any kind of genetic editing that will create a change that you will pass on to your offspring. So that would be illegal, but that’s not what’s happening here. And I don’t think there’s a regulatory framework that adequately captures it.”

Infectious disease and policy experts aren’t that concerned yet about the possibility of a biohacker unleashing a genetically modified super germ into the population.

“I think in the future that could be a problem,”says Caulfield, “but this isn’t something that would be easy to do in your garage. I think it’s complicated science. But having said that, the science is moving quickly. We need to think about how we are going to control the potential harms.”

You can find out more about the ‘wild’ people (mostly men) of early science in Richard Holmes’ 2008 book, The Age of Wonder: How the Romantic Generation Discovered the Beauty and Terror of Science.

Finally, should you be interested in connecting with synthetic biology enthusiasts, entrepreneurs, and others, SynBioBeta is more than a conference; it’s also an activity hub.

ETA January 25, 2018 (five minutes later): There are some CRISPR/CAS9 events taking place in Toronto, Canada on January 24 and 25, 2018. One is a workshop with Portuguese artist, Marta de Menezes, and the other is a panel discussion. See my January 10, 2018 posting for more details.

*’Segue: There is some Canadian content if you keep reading.’ and ‘Canadian content’ added January 25, 2018 six minutes after first publication.

ETA February 20, 2018: Sarah Zhang’s Feb. 20, 2018 article for The Atlantic revisits Josiah Zayner’s decision to inject himself with CRISPR,

When Josiah Zayner watched a biotech CEO drop his pants at a biohacking conference and inject himself with an untested herpes treatment, he realized things had gone off the rails.

Zayner is no stranger to stunts in biohacking—loosely defined as experiments, often on the self, that take place outside of traditional lab spaces. You might say he invented their latest incarnation: He’s sterilized his body to “transplant” his entire microbiome in front of a reporter. He’s squabbled with the FDA about selling a kit to make glow-in-the-dark beer. He’s extensively documented attempts to genetically engineer the color of his skin. And most notoriously, he injected his arm with DNA encoding for CRISPR that could theoretically enhance his muscles—in between taking swigs of Scotch at a live-streamed event during an October conference. (Experts say—and even Zayner himself in the live-stream conceded—it’s unlikely to work.)

So when Zayner saw Ascendance Biomedical’s CEO injecting himself on a live-stream earlier this month, you might say there was an uneasy flicker of recognition.

“Honestly, I kind of blame myself,” Zayner told me recently. He’s been in a soul-searching mood; he recently had a kid and the backlash to the CRISPR stunt in October [2017] had been getting to him. “There’s no doubt in my mind that somebody is going to end up hurt eventually,” he said.

Yup, it’s one of the reasons for rules; people take things too far. The trick is figuring out how to achieve balance between risk taking and recklessness.

Alberta adds a newish quantum nanotechnology research hub to the Canada’s quantum computing research scene

One of the winners in Canada’s 2017 federal budget announcement of the Pan-Canadian Artificial Intelligence Strategy was Edmonton, Alberta. It’s a fact which sometimes goes unnoticed while Canadians marvel at the wonderfulness found in Toronto and Montréal where it seems new initiatives and monies are being announced on a weekly basis (I exaggerate) for their AI (artificial intelligence) efforts.

Alberta’s quantum nanotechnology hub (graduate programme)

Intriguingly, it seems that Edmonton has higher aims than (an almost unnoticed) leadership in AI. Physicists at the University of Alberta have announced hopes to be just as successful as their AI brethren in a Nov. 27, 2017 article by Juris Graney for the Edmonton Journal,

Physicists at the University of Alberta [U of A] are hoping to emulate the success of their artificial intelligence studying counterparts in establishing the city and the province as the nucleus of quantum nanotechnology research in Canada and North America.

Google’s artificial intelligence research division DeepMind announced in July [2017] it had chosen Edmonton as its first international AI research lab, based on a long-running partnership with the U of A’s 10-person AI lab.

Retaining the brightest minds in the AI and machine-learning fields while enticing a global tech leader to Alberta was heralded as a coup for the province and the university.

It is something U of A physics professor John Davis believes the university’s new graduate program, Quanta, can help achieve in the world of quantum nanotechnology.

The field of quantum mechanics had long been a realm of theoretical science based on the theory that atomic and subatomic material like photons or electrons behave both as particles and waves.

“When you get right down to it, everything has both behaviours (particle and wave) and we can pick and choose certain scenarios which one of those properties we want to use,” he said.

But, Davis said, physicists and scientists are “now at the point where we understand quantum physics and are developing quantum technology to take to the marketplace.”

“Quantum computing used to be realm of science fiction, but now we’ve figured it out, it’s now a matter of engineering,” he said.

Quantum computing labs are being bought by large tech companies such as Google, IBM and Microsoft because they realize they are only a few years away from having this power, he said.

Those making the groundbreaking developments may want to commercialize their finds and take the technology to market and that is where Quanta comes in.

East vs. West—Again?

Ivan Semeniuk in his article, Quantum Supremacy, ignores any quantum research effort not located in either Waterloo, Ontario or metro Vancouver, British Columbia to describe a struggle between the East and the West (a standard Canadian trope). From Semeniuk’s Oct. 17, 2017 quantum article [link follows the excerpts] for the Globe and Mail’s October 2017 issue of the Report on Business (ROB),

 Lazaridis [Mike], of course, has experienced lost advantage first-hand. As co-founder and former co-CEO of Research in Motion (RIM, now called Blackberry), he made the smartphone an indispensable feature of the modern world, only to watch rivals such as Apple and Samsung wrest away Blackberry’s dominance. Now, at 56, he is engaged in a high-stakes race that will determine who will lead the next technology revolution. In the rolling heartland of southwestern Ontario, he is laying the foundation for what he envisions as a new Silicon Valley—a commercial hub based on the promise of quantum technology.

Semeniuk skips over the story of how Blackberry lost its advantage. I came onto that story late in the game when Blackberry was already in serious trouble due to a failure to recognize that the field they helped to create was moving in a new direction. If memory serves, they were trying to keep their technology wholly proprietary which meant that developers couldn’t easily create apps to extend the phone’s features. Blackberry also fought a legal battle in the US with a patent troll draining company resources and energy in proved to be a futile effort.

Since then Lazaridis has invested heavily in quantum research. He gave the University of Waterloo a serious chunk of money as they named their Quantum Nano Centre (QNC) after him and his wife, Ophelia (you can read all about it in my Sept. 25, 2012 posting about the then new centre). The best details for Lazaridis’ investments in Canada’s quantum technology are to be found on the Quantum Valley Investments, About QVI, History webpage,

History-bannerHistory has repeatedly demonstrated the power of research in physics to transform society.  As a student of history and a believer in the power of physics, Mike Lazaridis set out in 2000 to make real his bold vision to establish the Region of Waterloo as a world leading centre for physics research.  That is, a place where the best researchers in the world would come to do cutting-edge research and to collaborate with each other and in so doing, achieve transformative discoveries that would lead to the commercialization of breakthrough  technologies.

Establishing a World Class Centre in Quantum Research:

The first step in this regard was the establishment of the Perimeter Institute for Theoretical Physics.  Perimeter was established in 2000 as an independent theoretical physics research institute.  Mike started Perimeter with an initial pledge of $100 million (which at the time was approximately one third of his net worth).  Since that time, Mike and his family have donated a total of more than $170 million to the Perimeter Institute.  In addition to this unprecedented monetary support, Mike also devotes his time and influence to help lead and support the organization in everything from the raising of funds with government and private donors to helping to attract the top researchers from around the globe to it.  Mike’s efforts helped Perimeter achieve and grow its position as one of a handful of leading centres globally for theoretical research in fundamental physics.

Stephen HawkingPerimeter is located in a Governor-General award winning designed building in Waterloo.  Success in recruiting and resulting space requirements led to an expansion of the Perimeter facility.  A uniquely designed addition, which has been described as space-ship-like, was opened in 2011 as the Stephen Hawking Centre in recognition of one of the most famous physicists alive today who holds the position of Distinguished Visiting Research Chair at Perimeter and is a strong friend and supporter of the organization.

Recognizing the need for collaboration between theorists and experimentalists, in 2002, Mike applied his passion and his financial resources toward the establishment of The Institute for Quantum Computing at the University of Waterloo.  IQC was established as an experimental research institute focusing on quantum information.  Mike established IQC with an initial donation of $33.3 million.  Since that time, Mike and his family have donated a total of more than $120 million to the University of Waterloo for IQC and other related science initiatives.  As in the case of the Perimeter Institute, Mike devotes considerable time and influence to help lead and support IQC in fundraising and recruiting efforts.  Mike’s efforts have helped IQC become one of the top experimental physics research institutes in the world.

Quantum ComputingMike and Doug Fregin have been close friends since grade 5.  They are also co-founders of BlackBerry (formerly Research In Motion Limited).  Doug shares Mike’s passion for physics and supported Mike’s efforts at the Perimeter Institute with an initial gift of $10 million.  Since that time Doug has donated a total of $30 million to Perimeter Institute.  Separately, Doug helped establish the Waterloo Institute for Nanotechnology at the University of Waterloo with total gifts for $29 million.  As suggested by its name, WIN is devoted to research in the area of nanotechnology.  It has established as an area of primary focus the intersection of nanotechnology and quantum physics.

With a donation of $50 million from Mike which was matched by both the Government of Canada and the province of Ontario as well as a donation of $10 million from Doug, the University of Waterloo built the Mike & Ophelia Lazaridis Quantum-Nano Centre, a state of the art laboratory located on the main campus of the University of Waterloo that rivals the best facilities in the world.  QNC was opened in September 2012 and houses researchers from both IQC and WIN.

Leading the Establishment of Commercialization Culture for Quantum Technologies in Canada:

In the Research LabFor many years, theorists have been able to demonstrate the transformative powers of quantum mechanics on paper.  That said, converting these theories to experimentally demonstrable discoveries has, putting it mildly, been a challenge.  Many naysayers have suggested that achieving these discoveries was not possible and even the believers suggested that it could likely take decades to achieve these discoveries.  Recently, a buzz has been developing globally as experimentalists have been able to achieve demonstrable success with respect to Quantum Information based discoveries.  Local experimentalists are very much playing a leading role in this regard.  It is believed by many that breakthrough discoveries that will lead to commercialization opportunities may be achieved in the next few years and certainly within the next decade.

Recognizing the unique challenges for the commercialization of quantum technologies (including risk associated with uncertainty of success, complexity of the underlying science and high capital / equipment costs) Mike and Doug have chosen to once again lead by example.  The Quantum Valley Investment Fund will provide commercialization funding, expertise and support for researchers that develop breakthroughs in Quantum Information Science that can reasonably lead to new commercializable technologies and applications.  Their goal in establishing this Fund is to lead in the development of a commercialization infrastructure and culture for Quantum discoveries in Canada and thereby enable such discoveries to remain here.

Semeniuk goes on to set the stage for Waterloo/Lazaridis vs. Vancouver (from Semeniuk’s 2017 ROB article),

… as happened with Blackberry, the world is once again catching up. While Canada’s funding of quantum technology ranks among the top five in the world, the European Union, China, and the US are all accelerating their investments in the field. Tech giants such as Google [also known as Alphabet], Microsoft and IBM are ramping up programs to develop companies and other technologies based on quantum principles. Meanwhile, even as Lazaridis works to establish Waterloo as the country’s quantum hub, a Vancouver-area company has emerged to challenge that claim. The two camps—one methodically focused on the long game, the other keen to stake an early commercial lead—have sparked an East-West rivalry that many observers of the Canadian quantum scene are at a loss to explain.

Is it possible that some of the rivalry might be due to an influential individual who has invested heavily in a ‘quantum valley’ and has a history of trying to ‘own’ a technology?

Getting back to D-Wave Systems, the Vancouver company, I have written about them a number of times (particularly in 2015; for the full list: input D-Wave into the blog search engine). This June 26, 2015 posting includes a reference to an article in The Economist magazine about D-Wave’s commercial opportunities while the bulk of the posting is focused on a technical breakthrough.

Semeniuk offers an overview of the D-Wave Systems story,

D-Wave was born in 1999, the same year Lazaridis began to fund quantum science in Waterloo. From the start, D-Wave had a more immediate goal: to develop a new computer technology to bring to market. “We didn’t have money or facilities,” says Geordie Rose, a physics PhD who co0founded the company and served in various executive roles. …

The group soon concluded that the kind of machine most scientists were pursing based on so-called gate-model architecture was decades away from being realized—if ever. …

Instead, D-Wave pursued another idea, based on a principle dubbed “quantum annealing.” This approach seemed more likely to produce a working system, even if the application that would run on it were more limited. “The only thing we cared about was building the machine,” says Rose. “Nobody else was trying to solve the same problem.”

D-Wave debuted its first prototype at an event in California in February 2007 running it through a few basic problems such as solving a Sudoku puzzle and finding the optimal seating plan for a wedding reception. … “They just assumed we were hucksters,” says Hilton [Jeremy Hilton, D.Wave senior vice-president of systems]. Federico Spedalieri, a computer scientist at the University of Southern California’s [USC} Information Sciences Institute who has worked with D-Wave’s system, says the limited information the company provided about the machine’s operation provoked outright hostility. “I think that played against them a lot in the following years,” he says.

It seems Lazaridis is not the only one who likes to hold company information tightly.

Back to Semeniuk and D-Wave,

Today [October 2017], the Los Alamos National Laboratory owns a D-Wave machine, which costs about $15million. Others pay to access D-Wave systems remotely. This year , for example, Volkswagen fed data from thousands of Beijing taxis into a machine located in Burnaby [one of the municipalities that make up metro Vancouver] to study ways to optimize traffic flow.

But the application for which D-Wave has the hights hope is artificial intelligence. Any AI program hings on the on the “training” through which a computer acquires automated competence, and the 2000Q [a D-Wave computer] appears well suited to this task. …

Yet, for all the buzz D-Wave has generated, with several research teams outside Canada investigating its quantum annealing approach, the company has elicited little interest from the Waterloo hub. As a result, what might seem like a natural development—the Institute for Quantum Computing acquiring access to a D-Wave machine to explore and potentially improve its value—has not occurred. …

I am particularly interested in this comment as it concerns public funding (from Semeniuk’s article),

Vern Brownell, a former Goldman Sachs executive who became CEO of D-Wave in 2009, calls the lack of collaboration with Waterloo’s research community “ridiculous,” adding that his company’s efforts to establish closer ties have proven futile, “I’ll be blunt: I don’t think our relationship is good enough,” he says. Brownell also point out that, while  hundreds of millions in public funds have flowed into Waterloo’s ecosystem, little funding is available for  Canadian scientists wishing to make the most of D-Wave’s hardware—despite the fact that it remains unclear which core quantum technology will prove the most profitable.

There’s a lot more to Semeniuk’s article but this is the last excerpt,

The world isn’t waiting for Canada’s quantum rivals to forge a united front. Google, Microsoft, IBM, and Intel are racing to develop a gate-model quantum computer—the sector’s ultimate goal. (Google’s researchers have said they will unveil a significant development early next year.) With the U.K., Australia and Japan pouring money into quantum, Canada, an early leader, is under pressure to keep up. The federal government is currently developing  a strategy for supporting the country’s evolving quantum sector and, ultimately, getting a return on its approximately $1-billion investment over the past decade [emphasis mine].

I wonder where the “approximately $1-billion … ” figure came from. I ask because some years ago MP Peter Julian asked the government for information about how much Canadian federal money had been invested in nanotechnology. The government replied with sheets of paper (a pile approximately 2 inches high) that had funding disbursements from various ministries. Each ministry had its own method with different categories for listing disbursements and the titles for the research projects were not necessarily informative for anyone outside a narrow specialty. (Peter Julian’s assistant had kindly sent me a copy of the response they had received.) The bottom line is that it would have been close to impossible to determine the amount of federal funding devoted to nanotechnology using that data. So, where did the $1-billion figure come from?

In any event, it will be interesting to see how the Council of Canadian Academies assesses the ‘quantum’ situation in its more academically inclined, “The State of Science and Technology and Industrial Research and Development in Canada,” when it’s released later this year (2018).

Finally, you can find Semeniuk’s October 2017 article here but be aware it’s behind a paywall.

Whither we goest?

Despite any doubts one might have about Lazaridis’ approach to research and technology, his tremendous investment and support cannot be denied. Without him, Canada’s quantum research efforts would be substantially less significant. As for the ‘cowboys’ in Vancouver, it takes a certain temperament to found a start-up company and it seems the D-Wave folks have more in common with Lazaridis than they might like to admit. As for the Quanta graduate  programme, it’s early days yet and no one should ever count out Alberta.

Meanwhile, one can continue to hope that a more thoughtful approach to regional collaboration will be adopted so Canada can continue to blaze trails in the field of quantum research.

Nano- and neuro- together for nanoneuroscience

This is not the first time I’ve posted about nanotechnology and neuroscience (see this April 2, 2013 piece about then new brain science initiative in the US and Michael Berger’s  Nanowerk Spotlight article/review of an earlier paper covering the topic of nanotechnology and neuroscience).

Interestingly, the European Union (EU) had announced its two  $1B Euro research initiatives, the Human Brain Project and the Graphene Flagship (see my Jan. 28, 2013 posting about it),  months prior to the US brain research push. For those unfamiliar with the nanotechnology effort, graphene is a nanomaterial and there is high interest in its potential use in biomedical technology, thus partially connecting both EU projects.

In any event, Berger is highlighting a nanotechnology and neuroscience connection again in his Oct. 18, 2017 Nanowerk Spotlight article, or overview of, a new paper, which updates our understanding of the potential connections between the two fields (Note: A link has been removed),

Over the past several years, nanoscale analysis tools and in the design and synthesis of nanomaterials have generated optical, electrical, and chemical methods that can readily be adapted for use in neuroscience and brain activity mapping.

A review paper in Advanced Functional Materials (“Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping”) summarizes the basic concepts associated with neuroscience and the current journey of nanotechnology towards the study of neuron function by addressing various concerns on the significant role of nanomaterials in neuroscience and by describing the future applications of this emerging technology.

The collaboration between nanotechnology and neuroscience, though still at the early stages, utilizes broad concepts, such as drug delivery, cell protection, cell regeneration and differentiation, imaging and surgery, to give birth to novel clinical methods in neuroscience.

Ultimately, the clinical translation of nanoneuroscience implicates that central nervous system (CNS) diseases, including neurodevelopmental, neurodegenerative and psychiatric diseases, have the potential to be cured, while the industrial translation of nanoneuroscience indicates the need for advancement of brain-computer interface technologies.

Future Developing Arenas in Nanoneuroscience

The Brain Activity Map (BAM) Project aims to map the neural activity of every neuron across all neural circuits with the ultimate aim of curing diseases associated with the nervous system. The announcement of this collaborative, public-private research initiative in 2013 by President Obama has driven the surge in developing methods to elucidate neural circuitry. Three current developing arenas in the context of nanoneuroscience applications that will push such initiative forward are 1) optogenetics, 2) molecular/ion sensing and monitoring and 3) piezoelectric effects.

In their review, the authors discuss these aspects in detail.

Neurotoxicity of Nanomaterials

By engineering particles on the scale of molecular-level entities – proteins, lipid bilayers and nucleic acids – we can stereotactically interface with many of the components of cell systems, and at the cutting edge of this technology, we can begin to devise ways in which we can manipulate these components to our own ends. However, interfering with the internal environment of cells, especially neurons, is by no means simple.

“If we are to continue to make great strides in nanoneuroscience, functional investigations of nanomaterials must be complemented with robust toxicology studies,” the authors point out. “A database on the toxicity of materials that fully incorporates these findings for use in future schema must be developed. These databases should include information and data on 1) the chemical nature of the nanomaterials in complex aqueous environments; 2) the biological interactions of nanomaterials with chemical specificity; 3) the effects of various nanomaterial properties on living systems; and 4) a model for the simulation and computation of possible effects of nanomaterials in living systems across varying time and space. If we can establish such methods, it may be possible to design nanopharmaceuticals for improved research as well as quality of life.”

“However, challenges in nanoneuroscience are present in many forms, such as neurotoxicity; the inability to cross the blood-brain barrier [emphasis mine]; the need for greater specificity, bioavailability and short half-lives; and monitoring of disease treatment,” the authors conclude their review. “The nanoneurotoxicity surrounding these nanomaterials is a barrier that must be overcome for the translation of these applications from bench-to-bedside. While the challenges associated with nanoneuroscience seem unending, they represent opportunities for future work.”

I have a March 26, 2015 posting about Canadian researchers breaching the blood-brain barrier and an April 13, 2016 posting about US researchers at Cornell University also breaching the blood-brain barrier. Perhaps the “inability” mentioned in this Spotlight article means that it can’t be done consistently or that it hasn’t been achieved on humans.

Here’s a link to and a citation for the paper,

Nanotechnology for Neuroscience: Promising Approaches for Diagnostics, Therapeutics and Brain Activity Mapping by Anil Kumar, Aaron Tan, Joanna Wong, Jonathan Clayton Spagnoli, James Lam, Brianna Diane Blevins, Natasha G, Lewis Thorne, Keyoumars Ashkan, Jin Xie, and Hong Liu. Advanced Functional Materials Volume 27, Issue 39, October 19, 2017 DOI: 10.1002/adfm.201700489 Version of Record online: 14 AUG 2017

© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

I took a look at the authors’ information and found that most of these researchers are based in  China and in the UK, with a sole researcher based in the US.

Calligraphy ink and cancer treatment

Courtesy of ACS Omega and the researchers

Nice illustration! I wish I could credit the artist. For anyone who needs a little text to make sense of it, there’s a Sept. 27, 2017 news item on Nanowerk (Note: A link has been removed),

For hundreds of years, Chinese calligraphers have used a plant-based ink to create beautiful messages and art. Now, one group reports in ACS Omega (“New Application of Old Material: Chinese Traditional Ink for Photothermal Therapy of Metastatic Lymph Nodes”) that this ink could noninvasively and effectively treat cancer cells that spread, or metastasize, to lymph nodes.

A Sept. 27, 2017 American Chemical Society (ACS) news release, which originated the news item, reveals more about the research,

As cancer cells leave a tumor, they frequently make their way to lymph nodes, which are part of the immune system. In this case, the main treatment option is surgery, but this can result in complications. Photothermal therapy (PTT) is an emerging noninvasive treatment option in which nanomaterials are injected and accumulate in cancer cells. A laser heats up the nanomaterials, and this heat kills the cells. Many of these nanomaterials are expensive, difficult-to-make and toxic. However, a traditional Chinese ink called Hu-Kaiwen ink (Hu-ink) has similar properties to the nanomaterials used in PTT. For example, they are the same color, and are both carbon-based and stable in water. So Wuli Yang and colleagues wanted to see if Hu-ink could be a good alternative material for PTT.

The researchers analyzed Hu-ink and found that it consists of nanoparticles and thin layers of carbon. When Hu-ink was heated with a laser, its temperature rose by 131 degrees Fahrenheit, much higher than current nanomaterials. Under PPT conditions, the Hu-ink killed cancer cells in a laboratory dish, but under normal conditions, the ink was non-toxic. This was also the scenario observed in mice with tumors. The researchers also noted that Hu-ink could act as a probe to locate tumors and metastases because it absorbs near-infrared light, which goes through skin.

Being a little curious about Hu-ink’s similarity to nanomaterial, I looked for more detail in the the paper (Note: Links have been removed), From the: Introduction,

Photothermal therapy (PTT) is an emerging tumor treatment strategy, which utilizes hyperthermia generated from absorbed near-infrared (NIR) light energy by photoabsorbing agents to kill tumor cells.(7-13) Different from chemotherapy, surgical treatment, and radiotherapy, PTT is noninvasive and more efficient.(7, 14, 15) In the past decade, PTT with diverse nanomaterials to eliminate cancer metastases lymph nodes has attracted extensive attention by several groups, including our group.(3, 16-20) For instance, Liu and his co-workers developed a treatment method based on PEGylated single-walled carbon nanotubes for PTT of tumor sentinel lymph nodes and achieved remarkably improved treatment effect in an animal tumor model.(21) To meet the clinical practice, the potential metastasis of deeper lymph nodes was further ablated in our previous work, using magnetic graphene oxide as a theranostic agent.(22) However, preparation of these artificial nanomaterials usually requires high cost, complicated synthetic process, and unavoidably toxic catalyst or chemicals,(23, 24) which impede their future clinical application. For the clinical application, exploring an environment-friendly material with simple preparation procedure, good biocompatibility, and excellent therapeutic efficiency is still highly desired. [emphases mine]

From the: Preparation and Characterization of Hu-Ink

To obtain an applicable sample, the condensed Hu-ink was first diluted into aqueous dispersion with a lower concentration. The obtained Hu-ink dispersion without any further treatment was black in color and stable in physiological environment, including water, phosphate-buffered saline (PBS), and Roswell Park Memorial Institute (RPMI) 1640; furthermore, no aggregation was observed even after keeping undisturbed for 3 days (Figure 2a). The nanoscaled morphology of Hu-ink was examined by transmission electron microscopy (TEM) (Figure 2b), which demonstrates that Hu-ink mainly exist in the form of small aggregates. These small aggregates consist of a few nanoparticles with diameter of about 20–50 nm. Dynamic light scattering (DLS) measurement (Figure 2c) further shows that Hu-ink aqueous dispersion possesses a hydrodynamic diameter of about 186 nm (polydispersity index: 0.18), which was a crucial prerequisite for biomedical applications.(29) In the X-ray diffraction (XRD) pattern, no other characteristic peaks are found except carbon peak (Figure S1, Supporting Information), which confirms that the main component of Hu-ink is carbon.(25) Raman spectroscopy was a common tool to characterize graphene-related materials.(30) D band (∼1300 cm–1, corresponding to the defects) and G band (∼1600 cm–1, related to the sp2 carbon sites) peaks could be observed in Figure 2d with the ratio ID/IG = 0.96, which confirms the existence of graphene sheetlike structure in Hu-ink.(31) The UV–vis–NIR spectra (Figure 2e) also revealed that Hu-ink has high absorption in the NIR region around 650–900 nm, in which hemoglobin and water, the major absorbers of biological tissue, have their lowest absorption coefficient.(32) The high NIR absorption capability of Hu-ink encouraged us to investigate its photothermal properties.(33-35) Hu-ink dispersions with different concentrations were irradiated under an 808 nm laser (the commercial and widely used wavelength in photothermal therapy).(8-13) [emphases mine]

Curiosity satisfied! For those who’d like to investigate even further, here’s a link to and a citation for the paper,

New Application of Old Material: Chinese Traditional Ink for Photothermal Therapy of Metastatic Lymph Nodes by Sheng Wang, Yongbin Cao, Qin Zhang, Haibao Peng, Lei Liang, Qingguo Li, Shun Shen, Aimaier Tuerdi, Ye Xu, Sanjun Cai, and Wuli Yang. ACS Omega, 2017, 2 (8), pp 5170–5178 DOI: 10.1021/acsomega.7b00993 Publication Date (Web): August 30, 2017

Copyright © 2017 American Chemical Society

This paper appears to be open access.

Limitless energy and the International Thermonuclear Experimental Reactor (ITER)

Over 30 years in the dreaming, the International Thermonuclear Experimental Reactor (ITER) is now said to be 1/2 way to completing construction. A December 6, 2017 ITER press release (received via email) makes the joyful announcement,

ITER is proving that fusion is the future source of clean, abundant, safe and economic energy_

The International Thermonuclear Experimental Reactor (ITER), a project to prove that fusion power can be produced on a commercial scale and is sustainable, is now 50 percent built to initial operation. Fusion is the same energy source from the Sun that gives the Earth its light and warmth.

ITER will use hydrogen fusion, controlled by superconducting magnets, to produce massive heat energy. In the commercial machines that will follow, this heat will drive turbines to produce electricity with these positive benefits:

* Fusion energy is carbon-free and environmentally sustainable, yet much more powerful than fossil fuels. A pineapple-sized amount of hydrogen offers as much fusion energy as 10,000 tons of coal.

* ITER uses two forms of hydrogen fuel: deuterium, which is easily extracted from seawater; and tritium, which is bred from lithium inside the fusion reactor. The supply of fusion fuel for industry and megacities is abundant, enough for millions of years.

* When the fusion reaction is disrupted, the reactor simply shuts down-safely and without external assistance. Tiny amounts of fuel are used, about 2-3 grams at a time; so there is no physical possibility of a meltdown accident.

* Building and operating a fusion power plant is targeted to be comparable to the cost of a fossil fuel or nuclear fission plant. But unlike today’s nuclear plants, a fusion plant will not have the costs of high-level radioactive waste disposal. And unlike fossil fuel plants,
fusion will not have the environmental cost of releasing CO2 and other pollutants.

ITER is the most complex science project in human history. The hydrogen plasma will be heated to 150 million degrees Celsius, ten times hotter than the core of the Sun, to enable the fusion reaction. The process happens in a donut-shaped reactor, called a tokamak(*), which is surrounded by giant magnets that confine and circulate the superheated, ionized plasma, away from the metal walls. The superconducting magnets must be cooled to minus 269°C, as cold as interstellar space.

The ITER facility is being built in Southern France by a scientific partnership of 35 countries. ITER’s specialized components, roughly 10 million parts in total, are being manufactured in industrial facilities all over the world. They are subsequently shipped to the ITER worksite, where they must be assembled, piece-by-piece, into the final machine.

Each of the seven ITER members-the European Union, China, India, Japan, Korea, Russia, and the United States-is fabricating a significant portion of the machine. This adds to ITER’s complexity.

In a message dispatched on December 1 [2017] to top-level officials in ITER member governments, the ITER project reported that it had completed 50 percent of the “total construction work scope through First Plasma” (**). First Plasma, scheduled for December 2025, will be the first stage of operation for ITER as a functional machine.

“The stakes are very high for ITER,” writes Bernard Bigot, Ph.D., Director-General of ITER. “When we prove that fusion is a viable energy source, it will eventually replace burning fossil fuels, which are non-renewable and non-sustainable. Fusion will be complementary with wind, solar, and other renewable energies.

“ITER’s success has demanded extraordinary project management, systems engineering, and almost perfect integration of our work.

“Our design has taken advantage of the best expertise of every member’s scientific and industrial base. No country could do this alone. We are all learning from each other, for the world’s mutual benefit.”

The ITER 50 percent milestone is getting significant attention.

“We are fortunate that ITER and fusion has had the support of world leaders, historically and currently,” says Director-General Bigot. “The concept of the ITER project was conceived at the 1985 Geneva Summit between Ronald Reagan and Mikhail Gorbachev. When the ITER Agreement was signed in 2006, it was strongly supported by leaders such as French President Jacques Chirac, U.S. President George W. Bush, and Indian Prime Minister Manmohan Singh.

“More recently, President Macron and U.S. President Donald Trump exchanged letters about ITER after their meeting this past July. One month earlier, President Xi Jinping of China hosted Russian President Vladimir Putin and other world leaders in a showcase featuring ITER and fusion power at the World EXPO in Astana, Kazakhstan.

“We know that other leaders have been similarly involved behind the scenes. It is clear that each ITER member understands the value and importance of this project.”

Why use this complex manufacturing arrangement?

More than 80 percent of the cost of ITER, about $22 billion or EUR18 billion, is contributed in the form of components manufactured by the partners. Many of these massive components of the ITER machine must be precisely fitted-for example, 17-meter-high magnets with less than a millimeter of tolerance. Each component must be ready on time to fit into the Master Schedule for machine assembly.

Members asked for this deal for three reasons. First, it means that most of the ITER costs paid by any member are actually paid to that member’s companies; the funding stays in-country. Second, the companies working on ITER build new industrial expertise in major fields-such as electromagnetics, cryogenics, robotics, and materials science. Third, this new expertise leads to innovation and spin-offs in other fields.

For example, expertise gained working on ITER’s superconducting magnets is now being used to map the human brain more precisely than ever before.

The European Union is paying 45 percent of the cost; China, India, Japan, Korea, Russia, and the United States each contribute 9 percent equally. All members share in ITER’s technology; they receive equal access to the intellectual property and innovation that comes from building ITER.

When will commercial fusion plants be ready?

ITER scientists predict that fusion plants will start to come on line as soon as 2040. The exact timing, according to fusion experts, will depend on the level of public urgency and political will that translates to financial investment.

How much power will they provide?

The ITER tokamak will produce 500 megawatts of thermal power. This size is suitable for studying a “burning” or largely self-heating plasma, a state of matter that has never been produced in a controlled environment on Earth. In a burning plasma, most of the plasma heating comes from the fusion reaction itself. Studying the fusion science and technology at ITER’s scale will enable optimization of the plants that follow.

A commercial fusion plant will be designed with a slightly larger plasma chamber, for 10-15 times more electrical power. A 2,000-megawatt fusion electricity plant, for example, would supply 2 million homes.

How much would a fusion plant cost and how many will be needed?

The initial capital cost of a 2,000-megawatt fusion plant will be in the range of $10 billion. These capital costs will be offset by extremely low operating costs, negligible fuel costs, and infrequent component replacement costs over the 60-year-plus life of the plant. Capital costs will decrease with large-scale deployment of fusion plants.

At current electricity usage rates, one fusion plant would be more than enough to power a city the size of Washington, D.C. The entire D.C. metropolitan area could be powered with four fusion plants, with zero carbon emissions.

“If fusion power becomes universal, the use of electricity could be expanded greatly, to reduce the greenhouse gas emissions from transportation, buildings and industry,” predicts Dr. Bigot. “Providing clean, abundant, safe, economic energy will be a miracle for our planet.”

*     *     *


* “Tokamak” is a word of Russian origin meaning a toroidal or donut-shaped magnetic chamber. Tokamaks have been built and operated for the past six decades. They are today’s most advanced fusion device design.

** “Total construction work scope,” as used in ITER’s project performance metrics, includes design, component manufacturing, building construction, shipping and delivery, assembly, and installation.

It is an extraordinary project on many levels as Henry Fountain notes in a March 27, 2017 article for the New York Times (Note: Links have been removed),

At a dusty construction site here amid the limestone ridges of Provence, workers scurry around immense slabs of concrete arranged in a ring like a modern-day Stonehenge.

It looks like the beginnings of a large commercial power plant, but it is not. The project, called ITER, is an enormous, and enormously complex and costly, physics experiment. But if it succeeds, it could determine the power plants of the future and make an invaluable contribution to reducing planet-warming emissions.

ITER, short for International Thermonuclear Experimental Reactor (and pronounced EAT-er), is being built to test a long-held dream: that nuclear fusion, the atomic reaction that takes place in the sun and in hydrogen bombs, can be controlled to generate power.

ITER will produce heat, not electricity. But if it works — if it produces more energy than it consumes, which smaller fusion experiments so far have not been able to do — it could lead to plants that generate electricity without the climate-affecting carbon emissions of fossil-fuel plants or most of the hazards of existing nuclear reactors that split atoms rather than join them.

Success, however, has always seemed just a few decades away for ITER. The project has progressed in fits and starts for years, plagued by design and management problems that have led to long delays and ballooning costs.

ITER is moving ahead now, with a director-general, Bernard Bigot, who took over two years ago after an independent analysis that was highly critical of the project. Dr. Bigot, who previously ran France’s atomic energy agency, has earned high marks for resolving management problems and developing a realistic schedule based more on physics and engineering and less on politics.

The site here is now studded with tower cranes as crews work on the concrete structures that will support and surround the heart of the experiment, a doughnut-shaped chamber called a tokamak. This is where the fusion reactions will take place, within a plasma, a roiling cloud of ionized atoms so hot that it can be contained only by extremely strong magnetic fields.

Here’s a rendering of the proposed reactor,

Source: ITER Organization

It seems the folks at the New York Times decided to remove the notes which help make sense of this image. However, it does get the idea across.

If I read the article rightly, the official cost in March 2017 was around 22 B Euros and more will likely be needed. You can read Fountain’s article for more information about fusion and ITER or go to the ITER website.

I could have sworn a local (Vancouver area) company called General Fusion was involved in the ITER project but I can’t track down any sources for confirmation. The sole connection I could find is in a documentary about fusion technology,

Here’s a little context for the film from a July 4, 2017 General Fusion news release (Note: A link has been removed),

A new documentary featuring General Fusion has captured the exciting progress in fusion across the public and private sectors.

Let There Be Light made its international premiere at the South By Southwest (SXSW) music and film festival in March [2017] to critical acclaim. The film was quickly purchased by Amazon Video, where it will be available for more than 70 million users to stream.

Let There Be Light follows scientists at General Fusion, ITER and Lawrenceville Plasma Physics in their pursuit of a clean, safe and abundant source of energy to power the world.

The feature length documentary has screened internationally across Europe and North America. Most recently it was shown at the Hot Docs film festival in Toronto, where General Fusion founder and Chief Scientist Dr. Michel Laberge joined fellow fusion physicist Dr. Mark Henderson from ITER at a series of Q&A panels with the filmmakers.

Laberge and Henderson were also interviewed by the popular CBC radio science show Quirks and Quarks, discussing different approaches to fusion, its potential benefits, and the challenges it faces.

It is yet to be confirmed when the film will be release for streaming, check Amazon Video for details.

You can find out more about General Fusion here.

Brief final comment

ITER is a breathtaking effort but if you’ve read about other large scale projects such as building a railway across the Canadian Rocky Mountains, establishing telecommunications in an  astonishing number of countries around the world, getting someone to the moon, eliminating small pox, building the pyramids, etc., it seems standard operating procedure both for the successes I’ve described and for the failures we’ve forgotten. Where ITER will finally rest on the continuum between success and failure is yet to be determined but the problems experienced so far are not necessarily a predictor.

I wish the engineers, scientists, visionaries, and others great success with finding better ways to produce energy.

What helps you may hurt you (titanium dioxide nanoparticles and orthopedic implants)

From a Sept. 16, 2017 news item on Nanotechnology Now,

Researchers from the Mayo Clinic have proposed that negative cellular responses to titanium-based nanoparticles released from metal implants interfere in bone formation and resorption at the site of repair, resulting in implant loosening and joint pain. [emphasis mine]Their review of recent scientific evidence and call for further research to characterize the biological, physical, and chemical interactions between titanium dioxide nanoparticles and bone-forming cells is published in BioResearch Open Access, a peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers. The article is available free on theBioResearch Open Access website.

A Sept. 14, 2017 Mary Anne Liebert (Publishing) news release, which originated the news item,  mentions the authors,

Jie Yao, Eric Lewallen, PhD, David Lewallen, MD, Andre van Wijnen, PhD, and colleagues from the Mayo Clinic, Rochester, MN and Second Affiliated Hospital of Soochow University, China, coauthored the article entitled “Local Cellular Responses to Titanium Dioxide from Orthopedic Implants The authors examined the results of recently published studies of titanium-based implants, focusing on the direct and indirect effects of titanium dioxide nanoparticles on the viability and behavior of multiple bone-related cell types. They discuss the impact of particle size, aggregation, structure, and the specific extracellular and intracellular (if taken up by the cells) effects of titanium particle exposure.

“The adverse effects of metallic orthopedic particles generated from implants are of significant clinical interest given the large number of procedures carried out each year. This article reviews our current understanding of the clinical issues and highlights areas for future research,” says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.

Before getting to the abstract, here’s a link to and a citation for the paper,

Local Cellular Responses to Titanium Dioxide from Orthopedic Implants by Yao, Jie J.; Lewallen, Eric A.; Trousdale, William H.; Xu, Wei; Thaler, Roman; Salib, Christopher G.; Reina, Nicolas; Abdel, Matthew P.; Lewallen, David G.; and van Wijnenm, Andre J.. BioResearch Open Access. July 2017, 6(1): 94-103. https://doi.org/10.1089/biores.2017.0017 Published July 1, 2017

This paper is open access.

Vampire nanogenerators: 2017

Researchers have been working on ways to harvest energy from bloodstreams. I last wrote about this type of research in an April 3, 2009 posting about ‘vampire batteries ‘(for use in pacemakers). The latest work according to a Sept. 8, 2017 news item on Nanowerk comes from China,

Men build dams and huge turbines to turn the energy of waterfalls and tides into electricity. To produce hydropower on a much smaller scale, Chinese scientists have now developed a lightweight power generator based on carbon nanotube fibers suitable to convert even the energy of flowing blood in blood vessels into electricity. They describe their innovation in the journal Angewandte Chemie (“A One-Dimensional Fluidic Nanogenerator with a High Power Conversion Efficiency”)

A Sept. 8, 2017 Wiley Publishing news release (also on EurekAlert), which originated the news item, expands on the theme,

For thousands of years, people have used the energy of flowing or falling water for their purposes, first to power mechanical engines such as watermills, then to generate electricity by exploiting height differences in the landscape or sea tides. Using naturally flowing water as a sustainable power source has the advantage that there are (almost) no dependencies on weather or daylight. Even flexible, minute power generators that make use of the flow of biological fluids are conceivable. How such a system could work is explained by a research team from Fudan University in Shanghai, China. Huisheng Peng and his co-workers have developed a fiber with a thickness of less than a millimeter that generates electrical power when surrounded by flowing saline solution—in a thin tube or even in a blood vessel.

The construction principle of the fiber is quite simple. An ordered array of carbon nanotubes was continuously wrapped around a polymeric core. Carbon nanotubes are well known to be electroactive and mechanically stable; they can be spun and aligned in sheets. In the as-prepared electroactive threads, the carbon nanotube sheets coated the fiber core with a thickness of less than half a micron. For power generation, the thread or “fiber-shaped fluidic nanogenerator” (FFNG), as the authors call it, was connected to electrodes and immersed into flowing water or simply repeatedly dipped into a saline solution. “The electricity was derived from the relative movement between the FFNG and the solution,” the scientists explained. According to the theory, an electrical double layer is created around the fiber, and then the flowing solution distorts the symmetrical charge distribution, generating an electricity gradient along the long axis.

The power output efficiency of this system was high. Compared with other types of miniature energy-harvesting devices, the FFNG was reported to show a superior power conversion efficiency of more than 20%. Other advantages are elasticity, tunability, lightweight, and one-dimensionality, thus offering prospects of exciting technological applications. The FFNG can be made stretchable just by spinning the sheets around an elastic fiber substrate. If woven into fabrics, wearable electronics become thus a very interesting option for FFNG application. Another exciting application is the harvesting of electrical energy from the bloodstream for medical applications. First tests with frog nerves proved to be successful.

Here’s a link to and a citation for the paper,

A One-Dimensional Fluidic Nanogenerator with a High Power Conversion Efficiency by Yifan Xu, Dr. Peining Chen, Jing Zhang, Songlin Xie, Dr. Fang Wan, Jue Deng, Dr. Xunliang Cheng, Yajie Hu, Meng Liao, Dr. Bingjie Wang, Dr. Xuemei Sun, and Prof. Dr. Huisheng Peng. Angewandte Chemie International Edition DOI: 10.1002/anie.201706620 Version of Record online: 7 SEP 2017

© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim

This paper is behind a paywall.

Alan Copperman and Amanda Marcotte have a very US-centric discussion about CRISPR and germline editing (designer babies?)

For anyone who needs more information, I ran a three part series on CRISPR germline editing on August 15, 2017:

Part 1 opens the series with a basic description of CRISPR and the germline research that occasioned the series along with some of the ethical issues and patent disputes that are arising from this new technology. CRISPR and editing the germline in the US (part 1 of 3): In the beginning

Part 2 covers three critical responses to the reporting and between them describe the technology in more detail and the possibility of ‘designer babies’.  CRISPR and editing the germline in the US (part 2 of 3): ‘designer babies’?

Part 3 is all about public discussion or, rather, the lack of and need for according to a couple of social scientists. Informally, there is some discussion via pop culture and Joelle Renstrom notes although she is focused on the larger issues touched on by the television series, Orphan Black and as I touch on in my final comments. CRISPR and editing the germline in the US (part 3 of 3): public discussions and pop culture

The news about CRISPR and germline editing by a US team made a bit of a splash even being mentioned on Salon.com, which hardly ever covers any science news (except for some occasional climate change pieces). In a Sept. 4, 2017 salon.com item (an excerpt from the full interview) Amanda Marcotte talks with Dr. Alan Copperman director of the division of reproductive endocrinology and infertility at Mount Sinai Medical Center about the technology and its implications.  As noted in the headline, it’s a US-centric discussion where assumptions are made about who will be leading discussions about the future of the technology.

It’s been a while since I’ve watched it but I believe they do mention in passing that Chinese scientists published two studies about using CRISPR to edit the germline (i think there’s a third Chinese paper in the pipeline) before the American team announced its accomplishment in August 2017. By the way, the first paper by the Chinese caused quite the quandary in April 2015. (My May 14, 2015 posting covers some of the ethical issues; scroll down about 50% of the way for more about the impact of the published Chinese research.)

Also, you might want notice just how smooth Copperman’s responses are almost always emphasizing the benefits of the technology before usually answering the question. He’s had media training and he’s good at this.

They also talk about corn and CRISPR just about the time that agricultural research was announced. Interesting timing, non? (See my Oct. 11, 2017 posting about CRISPR edited corn coming to market in 2020.)

For anyone who wants to skip to the full Marcotte/Cooperman interview, go here on Facebook.